Incorporated in May 2001, Cordlife Group Limited ("Cordlife", together with its subsidiaries, the "Group"), is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012. The Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six key markets namely Singapore, Hong Kong, India, Indonesia and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers a comprehensive suite of diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services. In January 2018, Cordlife acquired HealthBaby Biotech (Hong Kong) Co., Limited, the largest private cord blood bank in Hong Kong. Through its majority-owned subsidiary, Stemlife Berhad in Malaysia, Cordlife controls an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife is also the first Singapore private cord blood bank to provide cord blood and cord lining banking services in Myanmar and Vietnam. The Group's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia are accredited by AABB (formerly known as the American Association of Blood Banks). In 2019, the Group has successfully performed 14 cord blood and 1 cord tissue releases to support medical treatment carried out at 6 healthcare institutions in 6 countries. The leading cord blood banks in the U.S. include Americord, Cord Blood Registry, Viacord. History 2019 Collaboration with Sandor on diagnostics in India. Designation of new Group CEO. Healthbaby is the First Private Cord Blood Bank in Hong Kong to Achieve FACT Accreditation. Entered into an indicative, non-binding proposal with Global Cord Blood Corporation. Geographical expansion in Bangladesh. PT.Cordlife Persada is the first Cord Blood Bank in Indonesia to achieve AABB accreditation. 2018–2015 HealthBaby Hong Kong launched Metascreen in May 2018. Advanced preventive healthcare in Singapore with the launch of new genetic testing service Plumcare DNA Advisor in April 2018. Acquired HealthBaby Hong Kong in January 2018. Cordlife Philippines achieved accreditation from AABB in July 2017. Extended Asia footprint to Vietnam with appointment of marketing agent in February 2017. Cordlife India achieved accreditation from College of American Pathologists ("CAP") in November 2016. Majority-owned Hong Kong Screening Centre achieved accreditation from CAP in November 2016. Appointed a marketing agent